CDC Considers New Medical Code to Classify Vaccine Injuries
The U.S. Centers for Disease Control and Prevention (CDC) is considering a proposal to formally recognize injuries associated with COVID-19 vaccinations as a diagnosable condition that can be recorded in medical records.1 The International Classification of Diseases (ICD-10), a standardized system used to classify diagnoses, symptoms, and procedures, could be updated under the proposal. Introduced […]
Canadian Government Overhauls Vaccine Injury Program
On Apr. 1, 2026, the Government of Canada assumed direct control of Canada’s vaccine injury compensation system, introducing changes aimed at improving how claims are processed and how support is delivered to vaccine injured individuals.1 The move followed an audit ordered by Health Minister Marjorie Michel in response to concerns about how the previous program […]
Patients Request Blood from Donors Who Have Not Received mRNA COVID-19 Shots
A growing number of patients are requesting blood transfusions from donors who have not gotten the COVID19 shot, according to a Mar. 28, 2026 report published in the journal Transfusion. In the report, researchers at Vanderbilt Medical Center Medical Center evaluated 15 cases over a period of two years between 2024 and 2025 in which […]
Pfizer/Valneva Aim for FDA Approval of mRNA Shot for Lyme Disease
On Mar. 23, 2026, Pfizer, Inc. of New York City, NY and Valneva SE of Saint-Herblain, France announced that they would seek regulatory approval from the U.S. Food and Drug Administration (FDA) for an experimental mRNA (messenger ribonucleic acid) biologic shot against Lyme disease that they have jointly been developing since 2020. The shot, designated […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early
After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]
FDA Launches New Consolidated Adverse Event Monitoring System
The U.S. Food and Drug Administration (FDA) has announced the launch of a new Adverse Event Monitoring System (AEMS) that consolidates adverse event reporting systems for different types of products licensed by the FDA, including the Vaccine Adverse Event Reporting System (VAERS) that was created under the 1986 National Childhood Vaccine Injury Act (NCVIA). The […]